BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29985537)

  • 21. Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Gen Thorac Cardiovasc Surg; 2016 Nov; 64(11):657-661. PubMed ID: 27515028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial measurements of KL-6 for monitoring activity and recurrence of interstitial pneumonia with anti-aminoacyl-tRNA synthetase antibody: A retrospective cohort study.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Kohno N; Hattori N
    Medicine (Baltimore); 2018 Dec; 97(49):e13542. PubMed ID: 30544464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
    Lee YS; Kim HC; Lee BY; Lee CK; Kim MY; Jang SJ; Lee HS; Moon J; Colby TV; Kim DS
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):216-223. PubMed ID: 27758986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Krebs von den Lungen-6 levels in psoriatic patients under treatment with biologics.
    Iwata H; Haga N; Sugai T; Fujita Y
    J Dermatol; 2021 Mar; 48(3):376-379. PubMed ID: 33146900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paradoxical exacerbation of latent interstitial pneumonia by secukinumab in a patient with psoriasis vulgaris.
    Hayashi M; Igarashi A; Okamura K; Suzuki T
    Br J Dermatol; 2019 Mar; 180(3):684-685. PubMed ID: 30430554
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
    Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
    BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in Serum KL-6 Level during Biologic Treatment for Psoriasis.
    Hoashi T; Miyazaki S; Ozaki S; Ichiyama S; Ito M; Kanda N; Saeki H
    J Nippon Med Sch; 2023; 90(2):194-201. PubMed ID: 37258257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of anti-tumor necrosis factor-α agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis.
    Hayashi M; Yanaba K; Umezawa Y; Asahina A; Nakagawa H
    J Dermatol; 2017 Sep; 44(9):1063-1066. PubMed ID: 28370220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunohistochemical Analysis of Krebs von den Lungen-6 (KL-6) Expression in Lung Tissue in Primary Lung Cancer Patients with High Serum KL-6 Levels].
    Yatsuyanagi E; Sato K; Sato K
    Kyobu Geka; 2015 Sep; 68(10):815-9. PubMed ID: 26329623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The diagnostic value of serum KL-6 in connective tissue disease associated interstitial lung disease].
    Wu X; Wu LJ; Luo CN; Shi YM; Zou JM; Meng XY
    Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(40):3172-3175. PubMed ID: 31694110
    [No Abstract]   [Full Text] [Related]  

  • 32. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of serum Krebs von den Lungen-6 levels in interstitial lung disease associated with dermatomyositis and secondary Sjögren's syndrome: a case report].
    Yu JF; Jin YB; He J; An Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):910-914. PubMed ID: 29045979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.
    Ishikawa N; Hattori N; Yokoyama A; Kohno N
    Respir Investig; 2012 Mar; 50(1):3-13. PubMed ID: 22554854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of serum biomarkers in patients with plaque psoriasis on secukinumab.
    Morita A; Tani Y; Matsumoto K; Yamaguchi M; Teshima R; Ohtsuki M
    J Dermatol; 2020 May; 47(5):452-457. PubMed ID: 32173900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi N; Takezaki S; Kobayashi I; Iwata N; Mori M; Nagai K; Nakano N; Miyoshi M; Kinjo N; Murata T; Masunaga K; Umebayashi H; Imagawa T; Agematsu K; Sato S; Kuwana M; Yamada M; Takei S; Yokota S; Koike K; Ariga T
    Rheumatology (Oxford); 2015 May; 54(5):784-91. PubMed ID: 25288783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic pleuroparenchymal fibroelastosis is characterized by an elevated serum level of surfactant protein-D, but Not Krebs von den Lungen-6.
    Sato S; Hanibuchi M; Fukuya A; Yabuki Y; Bando H; Yoshijima T; Goto H; Ogawa H; Nishioka Y
    Lung; 2014 Oct; 192(5):711-7. PubMed ID: 24880792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019.
    Chen H; Qin R; Huang Z; Luo W; Zheng P; Huang H; Hu H; Wang H; Sun B
    Cytokine; 2021 Dec; 148():155513. PubMed ID: 34507246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.
    Shigemura M; Nasuhara Y; Konno S; Shimizu C; Matsuno K; Yamguchi E; Nishimura M
    J Transl Med; 2012 Jul; 10():111. PubMed ID: 22650152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.